#United States #Quest Diagnostics #Secaucus #Corporate Responsibility #Health Initiatives

Quest Diagnostics Unveils Its 2024 Corporate Responsibility Report

Quest Diagnostics, a prominent name in diagnostic information services, has recently published its 2024 Corporate Responsibility Report. Under the theme "Care Starts Here," the report underscores the vital role the company plays in enhancing the healthcare landscape, particularly through laboratory diagnostics that empower individuals to make informed health decisions.

Jim Davis, the Chairman, CEO, and President of Quest Diagnostics, stated, "Care runs deep in the Quest culture, energizing our more than 55,000 colleagues to deliver on the Quest Purpose, working together to create a healthier world, one life at a time." The report elaborates on several key initiatives from 2024 aimed at improving healthcare accessibility and quality.

One of the standout achievements noted in the report is Quest’s supportive role in nearly 40 programs through the Quest Diagnostics Foundation. These initiatives are focused on enhancing clinical and community health outcomes. Additionally, the company donated around $13 million in corporate giving and foundation grants to various organizations dedicated to disaster relief, health research, and other local health initiatives.

To further enhance healthcare access, Quest provided about one million donated or discounted test requisitions, which often encompass several tests, enabling more individuals to receive critical health screenings. Additionally, the company’s Employee Matching Gifts program successfully generated donations for over 650 nonprofits, demonstrating its commitment to community involvement.

In terms of governance and leadership, Quest Diagnostics extended its board by adding Robert Carter, a former Executive Vice President and Chief Information Officer at FedEx. His experience in technology and logistics is expected to bolster Quest's ongoing improvements in quality and efficiency. The report also highlighted the introduction of approximately 50 innovative testing services aimed at improving diagnosis and treatment access for conditions like Alzheimer’s disease, various cancers, and HIV.

Furthermore, Quest Diagnostics made a commendable investment in supporting small businesses, spending about $300 million on goods and services from small U.S.-based vendors. This effort not only stimulates local economies but also aligns with their broader commitment to ethical and sustainable business practices.

The report also provided insights into environmental sustainability efforts. Quest is taking concrete steps to reduce its reliance on electricity and single-use plastics while advancing the transition of its U.S. courier fleet to electric and hybrid vehicles. Noteworthy progress has been made toward achieving International Organization for Standardization (ISO) 14001-2015 certification for environmental management in two additional facilities located in Marlborough, Massachusetts, and Lewisville, Texas.

As the year progresses, the company looks to build upon the momentum from 2024 to further its goals in corporate responsibility. "We look forward to building on this momentum throughout 2025 and beyond," Davis added, emphasizing the company's continuous pursuit of innovative solutions that benefit patients, employees, and communities alike.

To learn more about Quest Diagnostics' initiatives and accomplishments in 2024, the full report is available for review on their official website. Through its dedicated efforts, Quest Diagnostics remains a key player in the healthcare sector, committed to improving health outcomes and fostering community wellness across the nation.